Trial of Patterned Oral Somatosensory Entrainment for Shortening Time to Oral Feeding
NCT ID: NCT01158391
Last Updated: 2016-05-18
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
210 participants
INTERVENTIONAL
2010-05-31
2016-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The secondary hypothesis is that the infants in the NTrainer System® experimental group will have shorter lengths of stay.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Oral Entrainment on Suck Development of Preterm Infants Born 23 to 34 Weeks Gestational Age (GA)
NCT01069744
Use Of Nfant(R) Technology Feeding System For Infants Less Than 30 Weeks GA
NCT04256889
Comparison of Non-nutritive Suck (NNS) Measures to Clinical Estimates of Suck and Feeding Readiness in Preterm Infants
NCT01069731
Direct Swallowing Training and Oral Sensorimotor Stimulation in Preterm Infants
NCT02508571
Effects of the Oral Stimulation Program in Extreme Preterm Infants
NCT03025815
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The interventions (Treatment vs Control) will be initiated simultaneously with tube (gavage) feeds as early as 30 weeks post-menstrual age. Before and during each training session the infant will be evaluated for the following criteria:
Criteria for Initiation of each intervention:
1. Not on continuous vasopressor medications
2. Feeding in previous 48 hours.
3. Not mechanically ventilated. If the infant is on CPAP or Nasal cannula \>2 liters per minute, then the FiO2 must be \<40%.
Criteria for Exiting an Intervention Session:
1. If during an intervention the baby experiences Apnea/Bradycardic/Desaturation events requiring nursing stimulation or intervention during the training--hold future interventions for one session.
2. If the interventions are held for 3 consecutive sessions, hold interventions for a full day (24 hours).
3. If interventions are held for 3 days (72 hours) and if GA is \<32 weeks when ready to restart therapy sessions, then complete another 10 days of interventions.
4. If interventions are held for 3 days (72 hours) and if GA is \>32 weeks when ready to restart therapy, then complete the remaining N interventions sessions for a total of 10 days of therapy.
5. If interventions are held for 3 days (72 hours) and the infant is on full oral feeds when ready to restart therapy interventions then discontinue any remaining interventions sessions.
The Interventions
Infants in the Treatment and Control group will receive orocutaneous stimulation up to four times daily during the first 30 minutes of a tube (gavage) feeding session to achieve an average of 30 therapy sessions distributed over a two week period.
Infants assigned to the either group will be offered the pacifier by gently placing the pacifier on the lips. The pacifier should not be forced into the mouth and should not be moved in any manner that would represent any form of patterned input such as moving the pacifier in and out, tapping on the lips or face or massaging the mouth or oral facial structure.
All other preparatory, infant positioning, and sampling conditions will be equal among groups. The healthcare team will continue to promote feeding and growth at the standard of care for babies in both groups.
Treatment Group
Infants in the Treatment group will receive the NTrainer System® patterned synthetic orocutaneous stimulation. A single NTrainer intervention runs for 20 minutes and involves three 3 minute sessions during which the pacifier pulses. The pulsing sessions are separated by 5.5 min breaks where the pacifier is quiet.
Control Group
Infants assigned to the control group will receive an orocutaneous intervention in which the infant will be offered a 20 minute non-nutritive sucking opportunity with a 'quiet' pacifier.
Breast Feeding Non-nutritive breastfeeding and nutritive breastfeeding practice will not be altered or changed by the interventions. The availability of the mother will be taken into consideration for the scheduling of any intervention sessions and no study intervention will interfere with breastfeeding behavior.
Safety To help ensure the safety of the study participants the heart rate, oxygen saturation, and blood pressure will be monitored throughout the therapy session.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
NTrainer® Intervention
NTrainer® Intervention - Infants in the experimental group will receive the NTrainer System patterned synthetic orocutaneous stimulation during the first 30 minutes of a tube (gavage) feeding session. The intervention may be provided up to 4 times daily to achieve an average of 30 sessions distributed over a two week period.
NTrainer® Intervention
Control Intervention
Control Intervention - Infants in the Control group will be provided orocutaneous stimulation with a 'quiet pacifier' during the first 30 minutes of a tube (gavage) feeding session. The intervention may be provided up to 4 times daily to achieve an average of 30 sessions distributed over a two week period.
Control Intervention
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
NTrainer® Intervention
Control Intervention
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Congenital anomalies included but not limited to
* craniofacial malformation
* cyanotic congenital heart disease
* gastroschisis
* omphalocele
* diaphragmatic hernia or other major gastrointestinal anomalies
* Major neurological anomaly
* Infants with history of surgical necrotizing enterocolitis (stage III)
* Infants with vocal cord paralysis
* Infants with neonatal seizures
* Infants with meningitis at time of enrollment
* Infants who are nippling all feeds at the time of enrollment
* Infants with narcotic abstinence syndrome (NAS)
* Infants enrolled in another clinical study
26 Weeks
31 Weeks
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Innara Health, Inc.
INDUSTRY
KC BioMediX, Inc
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Dongli Song, MD
Role: PRINCIPAL_INVESTIGATOR
Santa Clara Valley Medical Center
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Santa Clara Valleye Medical Center
San Jose, California, United States
Montefiore Medical Center Weiler Hopsital
The Bronx, New York, United States
Montefiore Medical Center - Wakefield Hopsital
The Bronx, New York, United States
Cook Children's Medical Center
Fort Worth, Texas, United States
North Central Baptist Hospital
San Antonio, Texas, United States
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Song D, Jegatheesan P, Nafday S, Ahmad KA, Nedrelow J, Wearden M, Nemerofsky S, Pooley S, Thompson D, Vail D, Cornejo T, Cohen Z, Govindaswami B. Patterned frequency-modulated oral stimulation in preterm infants: A multicenter randomized controlled trial. PLoS One. 2019 Feb 28;14(2):e0212675. doi: 10.1371/journal.pone.0212675. eCollection 2019.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
KC_BMDX_002
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.